<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P08067123A0248 According to the results of assays obtained with the use of assay systems ORTHO ELISA and ABBOTT HCV EIA (USA), the detection rate of anti-HCV-C100-3 among primary blood donors in Moscow was 1.37% and was not different from that among HBsAg carriers (1.8%) and among donors with anti-HCV-C100-3 in the blood (1.6%) (p &lt; 0.01)."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="341" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="110" end="124" Gene="anti-HCV-C100-3"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="195" end="199" Gene="HBsAg"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="232" end="246" Gene="anti-HCV-C100-3"/></CAS>